{
    "code": "51058965",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058965",
    "time": "2016-07-22 03:12:54",
    "許可證字號": "衛部藥製字第058965號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/12\/21",
    "發證日期": "104\/12\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105896502",
    "中文品名": "安庇美錠20毫克",
    "英文品名": "ABIOMAY Tablets 20mg",
    "適應症": "成人和青少年（13至17歲）的思覺失調症。成人和兒童（10至17歲）的雙極性疾患之躁症發作及混合型發作，可單獨使用或做為鋰鹽或Valproate的輔助治療。第一型雙極性疾患維持治療之鋰鹽或Valproate的輔助治療。重鬱症之輔助治療。兒童（6至17歲）的自閉性疾患伴隨之急躁易怒。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠PTP 鋁箔盒裝 2-1000錠塑膠瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "ARIPIPRAZOLE",
    "限制項目": [
        "01國產",
        "24監視期滿學名藥"
    ],
    "申請商名稱": "1608501100  歐美藥品有限公司",
    "申請商地址": "台北市中山區明水路365號(實際營業地址:1樓及地下1樓)",
    "主製造廠": {
        "製造廠名稱": "0413004300  五洲製藥股份有限公司",
        "製造廠廠址": "桃園市新屋區赤欄里17之1號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200095400",
            "成分名稱": "ARIPIPRAZOLE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010589650001-105-04-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058965&Seq=001&Type=9"
        },
        {
            "title": "51058965-3-105-04-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058965&Seq=003&Type=8"
        },
        {
            "title": "51058965-2-105-04-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058965&Seq=002&Type=8"
        },
        {
            "title": "51058965-1-105-04-26.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058965&Seq=001&Type=8"
        }
    ]
}